Beth Dobbin, who represented Great Britain in the 200-meter sprint at the Tokyo Olympics in 2021, has shared the reality of her current health struggles. Five years after competing on the world stage, Dobbin has been diagnosed with Myalgic Encephalomyelitis (ME), a chronic and complex condition characterized by extreme fatigue and physical limitations. The illness has drastically altered her daily life, leaving her bedbound for approximately 22 hours each day.

ME, often referred to as Chronic Fatigue Syndrome, is a condition for which there is currently no known cure. The diagnosis marks a stark contrast to Dobbin’s previous life as an elite athlete, where her days were defined by rigorous training and international competition. While the report from BBC Sport highlights the severity of her condition, it does not detail the specific medical timeline or the exact onset of her symptoms following her Olympic appearance. Dobbin’s transition from a high-performance sprinter to someone struggling with the basic demands of daily living underscores the debilitating nature of the illness, which affects millions globally but remains difficult to treat. Her story serves as a public look into the life of an athlete whose career was cut short by a condition that is often misunderstood or under-researched in the medical community.